triazoles has been researched along with Bone Diseases, Infectious in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berry, A; Cassaing, S; Hajj, LE; Khatibi, S; Linas, MD; Magnaval, JF; Marchou, B; Massip, P; Porte, L; Sans, N | 1 |
| Begueret, H; Beylot-Barry, M; Couprie, B; Domergue, V; Doutre, MS; Huerre, M; Orlandini, V; Tunon de Lara, M | 1 |
2 other study(ies) available for triazoles and Bone Diseases, Infectious
| Article | Year |
|---|---|
Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole.
Topics: Antifungal Agents; Bone Diseases, Infectious; Female; Humans; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Tarsal Bones; Tibia; Treatment Outcome; Triazoles; Voriconazole | 2006 |
[Cutaneous, pulmonary and bone aspergillosis in a patient presumed immunocompetent presenting subacute cutaneous lupus erythematosus].
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bone Diseases, Infectious; Caspofungin; Echinocandins; Humans; Lipopeptides; Lung; Lung Diseases, Fungal; Lupus Erythematosus, Systemic; Male; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole | 2008 |